Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells

Circulation Research

Volumn 86, Issue 10, 2000, Pages 1038-1046

  Chan, Shiu Wan ^a   Hegyi, Laszlo ^a   Scott, Stephen ^a   Cary, Nathaniel R B ^b   Weissberg, Peter L ^a   Bennett, Martin R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Remodeling; Vascular smooth muscle cell

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; FAS ANTIGEN;

APOPTOSIS; ARTICLE; CELL HETEROGENEITY; CELL SUBPOPULATION; CELL SURFACE; CORONARY ARTERY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034717298     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.10.1038     Document Type: Article

References (54)

1. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson M-D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 1993;262:695-700.
2. Tschopp J, Irmler M, Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol. 1998;10:552-558.
3. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 1999; 41:361-368.
4. Cho A, Courtman D, Langille L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
5. Pollman MJ, Hall JL, Gibbons GH. Acute induction of medial cell apoptosis by angioplasty injury: regulation by redox-sensitive mechanisms. Circulation. 1997;96(suppl I):I-560. Abstract.
6. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997; 326:1-16.
7. Ashkenazi A, Dixit V. Death receptors: signaling and modulation. Science. 1998;281:1305-1308.
8. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 1998;187:587-600.
9. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P. Constitutive and induced expression of APO-1, a new member of the nerve growth-factor tumor-necrosis-factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 1993;69:415-429.
10. Nagata S, Golstein P. The Fas death factor. Science. 1995;267: 1449-1456.
11. Bennett M, Macdonald K, Chan S-W, Simari R, Luzio J, Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 1998;282:290-293.
12. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A, Krammer PH. Expression of APO-1 (Cd95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer. 1994;57:371-377.
13. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini JC, Tschopp J. Melanoma cell expression of fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science. 1996;274:1363-1366.
14. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor-cells: a mechanism of immune evasion. Nat Med. 1996;2:1361-1366.
15. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998;396:699-703.
16. Cory S. Apoptosis: fascinating death factor. Nature. 1994;367:317-318.
17. Reed J. Double identity for proteins of the Bcl-2 family. Nature. 1997; 387:773-776.
18. Irmler M, Thome M, Hahne M, Schneider P, Hofmann B, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190-195.
19. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349-353.
20. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300-304.
21. Deveraux QL, Roy N, Stennicke HR, VanArsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998;17:2215-2223.
22. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
23. Bennett MR, Macdonald K, Chan SW, Boyle JJ, Weissberg PL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998;82:704-712.
24. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2200-2208.
25. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med. 1999;5:90-96.
26. Chinnaiyan A, O'Rourke K, Tewari M, Dixit V. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
27. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. Rip: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 1995;81:513-523.
28. Nicholson D, Ali A, Thornberry N, Vaillancourt J, Ding C, Gallant M, Gareau Y, Griffin P, Labelle M, Lazebnik Y, Munday N, Raju S, Smulson M, Yamin T, Yu V, Miller D. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995; 376:37-43.
29. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272:17907-17911.
30. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 1997;16:2794-2804.
31. Thornberry N, Lazebnik Y. Caspases: enemies within. Science. 1998;281: 1312-1316.
32. Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis. Circ Res. 1997;81:591-599.
33. Geng Y, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β converting enzyme. Am J Pathol. 1995;147:251-266.
34. Han DKM, Wright ME, Dixit VM, Pruitt R, Soe HS, Lynch DH, Schwartz SM. Evidence for escape of apoptosis by loss of Fas in atherosclerotic plaque smooth muscle. Circulation. 1996;94:2311-2311.
35. Rouquet N, Pages J, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol. 1996;6:1192-1195.
36. Rodriguez I, Matsuura K. Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against fas-mediated fulminant liver destruction and death. J Exp Med. 1996;184:2067-2072.
37. Yeh WC, de la Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El Deiry WS, Lowe SW, Goeddel DV, Mak TW. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998; 279:1954-1958.
38. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 1998;17: 6888-6902.
39. Dubrez L, Savoy I, Hamman A, Solary E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 1996;15:5504-5512.
40. Armstrong R, Aja T, Xiang J, Gaur S, Krebs J, Hoang K, Bai X, Korsmeyer J, Karanewsky D, Fritz L, Tomaselli K. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem. 1996;271:16850-16855.
41. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-Iike and CPP32-like proteases during Fas-mediated apoptosis. Nature. 1996;380:723-726.
42. Schlegel J, Peters I, Orrenius S, Miller D, Thornberry A, Yamin T, Nicholson D. CPP32 apopain is a key interleukin-1β converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem. 1996;271:1841-1844.
43. Darmon A, Bleackley R. An interleukin-1β converting enzyme-like protease is a key component of Fas-mediated apoptosis. J Biol Chem. 1996;271:21699-21702.
44. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW. Essential contribution of caspase 3 CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998;12: 806-819.
45. Sata M, Perlman HR, Muruve DA, Silver M, Ikebe M, Libermann TA, Oettgen P, Walsh K. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci U S A. 1998;95:1213-1217.
46. Sata M, Walsh K. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med. 1998; 4:415-420.
47. Majesky MW, Schwartz SM. Smooth muscle diversity in arterial wound repair. Toxicol Pathol. 1990;18:554-559.
48. Lemire J, Covin C, White S, Giachelli C, Schwartz S. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 1994; 144:1068-1081.
49. Bochaton-Piallat M-L, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat aortic smooth muscle cell clones. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
50. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97:814-825.
51. Fujita H, Shimokado K, Yutani C, Takaichi S, Masuda J, Ogata J. Human neonatal and adult vascular smooth muscle cells in culture. Exp Mol Pathol. 1993;58:25-39.
52. Bjorkerud S. Cultivated human arterial smooth muscle displays heterogeneous pattern of growth and phenotypic variation. Lab Invest. 1985; 53:303-310.
53. Bochaton-Piallat M-L. Gabbiani F, Gabbiani G. Heterogeneity of rat aortic smooth muscle cell replication during development: correlation with replicative activity after experimental endothelial denudation in adults. J Submicrosc Cytol Pathol. 1994;26:1-8.
54. Babaev VR, Bobryshev YV, Stenina OV, Tararak EM, Gabbiani G. Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol. 1990;136:1031-1042.